Trial Profile
A study of brain amyloid and tau deposition using Florbetapir and T807 in young onset Alzheimer's disease
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary) ; Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 11 Feb 2016 Planned End Date changed from 30 Nov 2015 to 30 Oct 2016 as reported by United Kingdom Clinical Research Network.
- 26 Nov 2015 New trial record